264 related articles for article (PubMed ID: 27286837)
1. [Hyperuricemia and gout : New aspects of an old disease].
Witt M; Schulze-Koops H
Internist (Berl); 2016 Jul; 57(7):656-65. PubMed ID: 27286837
[TBL] [Abstract][Full Text] [Related]
2. Dual-Energy CT in Patients with Suspected Gouty Arthritis: Effects on Treatment Regimen and Clinical Outcome.
Metzger SC; Koehm M; Wichmann JL; Buettner S; Scholtz JE; Beeres M; Kerl JM; Albrecht MH; Hammerstingl R; Vogl TJ; Bauer RW
Acad Radiol; 2016 Mar; 23(3):267-72. PubMed ID: 26749327
[TBL] [Abstract][Full Text] [Related]
3. [Hyperuricemia. When and how to treat?].
Reuss-Borst MA
Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.
Shen Z; Tieu K; Wilson D; Bucci G; Gillen M; Lee C; Kerr B
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):377-387. PubMed ID: 28074640
[TBL] [Abstract][Full Text] [Related]
5. Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
Fanouriakis A; Karantanas A; Fragouli E; Repa A; Sidiropoulos P
Rheumatology (Oxford); 2014 Apr; 53(4):764-6. PubMed ID: 24185764
[No Abstract] [Full Text] [Related]
6. Efficacy and Safety of Lesinurad in Patients with Hyperuricemia Associated with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wu JY; Chang YT; Lin YC; Lee CH; Loh EW; Wu MY; Chang YS; Tam KW
Pharmacotherapy; 2018 Nov; 38(11):1106-1119. PubMed ID: 30246299
[TBL] [Abstract][Full Text] [Related]
7. [Gout].
Gröbner W; Zöllner N
Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
[TBL] [Abstract][Full Text] [Related]
8. Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.
Jones G; Panova E; Day R
Drug Des Devel Ther; 2017; 11():3077-3081. PubMed ID: 29123379
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
Dalbeth N; Jones G; Terkeltaub R; Khanna D; Fung M; Baumgartner S; Perez-Ruiz F
Arthritis Res Ther; 2019 Jan; 21(1):8. PubMed ID: 30616614
[TBL] [Abstract][Full Text] [Related]
10. [Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].
Kiltz U; Alten R; Fleck M; Krüger K; Manger B; Müller-Ladner U; Nüsslein H; Reuss-Borst M; Schwarting A; Schulze-Koops H; Tausche AK; Braun J
Z Rheumatol; 2017 Mar; 76(2):118-124. PubMed ID: 28078432
[TBL] [Abstract][Full Text] [Related]
11. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure.
Maekawa M; Tomida H; Aoki T; Hishida M; Morinaga T; Tamai H
Intern Med; 2014; 53(6):609-12. PubMed ID: 24633032
[TBL] [Abstract][Full Text] [Related]
13. [How to select and use urate lowering agents for hyperuricemia].
Yamanaka H
Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
[TBL] [Abstract][Full Text] [Related]
14. Radiologic case study.
Sakamoto FA; Winalski CS; Rodrigues LC; Fernandes AR; Bortoletto A; Sundaram M
Orthopedics; 2012 May; 35(5):353-437. PubMed ID: 22588390
[No Abstract] [Full Text] [Related]
15. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Fleischmann R; Kerr B; Yeh LT; Suster M; Shen Z; Polvent E; Hingorani V; Quart B; Manhard K; Miner JN; Baumgartner S;
Rheumatology (Oxford); 2014 Dec; 53(12):2167-74. PubMed ID: 24509406
[TBL] [Abstract][Full Text] [Related]
16. Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.
JAMA; 2018 Jan; 319(2):188-189. PubMed ID: 29318274
[No Abstract] [Full Text] [Related]
17. Advances in the management of gout and hyperuricaemia.
Hoskison TK; Wortmann RL
Scand J Rheumatol; 2006; 35(4):251-60. PubMed ID: 16882587
[TBL] [Abstract][Full Text] [Related]
18. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
McDonald E; Marino C
Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
[TBL] [Abstract][Full Text] [Related]
19. [Why anti-gout agents when patients with gouty arthritis are to be surgically treated].
Hørslev-Petersen K
Ugeskr Laeger; 1998 Apr; 160(15):2233. PubMed ID: 9599516
[No Abstract] [Full Text] [Related]
20. [Differential diagnosis and therapy of gout].
Reuss-Borst M
Med Klin (Munich); 2009 Sep; 104(9):710-20, quiz 721-2. PubMed ID: 19779676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
